Related Experiment Video
Updated: Jun 19, 2026

23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Community involvement in HIV and tuberculosis research
1Treatment Action Group, New York, NY 10012, USA. markhar@gmail.com
Journal of Acquired Immune Deficiency Syndromes (1999)
|October 28, 2009
Summary
People living with HIV (human immunodeficiency virus) have driven advancements in HIV treatment and research. Their advocacy now targets tuberculosis (TB) research, crucial for developing new diagnostics and treatments for co-infected individuals.
Area of Science:
- Public Health
- Infectious Disease Research
- Health Policy Advocacy
Background:
- The human immunodeficiency virus (HIV) pandemic has seen affected communities actively lead crisis response efforts since the 1980s.
- HIV treatment activism has successfully influenced regulatory bodies for expanded access to experimental therapies and accelerated drug approvals.
- Involvement of people with HIV and advocates in clinical trial design, conduct, and evaluation has been a significant achievement.
Purpose of the Study:
- To highlight the critical role of HIV treatment activists in advancing HIV research and treatment access.
- To explore the adaptation of HIV activism strategies to address the urgent needs in tuberculosis (TB) research and programs.
- To emphasize the necessity of activist efforts in accelerating the development of diagnostics, treatments, and vaccines for TB, particularly in people living with HIV.
Main Methods:
- Review of historical achievements of the HIV treatment activist movement.
- Analysis of the adaptation of these advocacy skills to tuberculosis research and programs.
- Case study approach examining the implementation of collaborative HIV/TB activities and their impact on health systems.
Main Results:
- HIV activism has led to expanded access to experimental treatments and accelerated drug approvals based on surrogate markers.
- Activists have been integrated into various stages of the HIV research system, enhancing trial relevance and conduct.
- The skills and experiences of HIV activists are being applied to TB research, addressing the lack of adequate interventions for co-infected individuals.
Conclusions:
- The proactive engagement of people with HIV has been instrumental in shaping the trajectory of HIV research and care.
- Activist-driven advocacy is vital for accelerating the development and implementation of new TB diagnostics, drugs, and vaccines.
- Scaling up collaborative HIV/TB programs, informed by activist experiences, strengthens overall health systems and reduces the TB burden among people with HIV.
Related Concept Videos
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
